Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPER: Intrathecal Morphine vs CMM for Chronic Pain
NCT04096391Completed
- Sponsor
- Restorative Pain Institute
- Start
- Jun 2019
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in chronic pain (2 arms), sponsored by Restorative Pain Institute. Primary endpoint: Numeric Rating Scale at 12 months. Started Jun 2019; status: completed.
02
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04096391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04096391.